|
SC4MOL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04281036531029E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88657986402541E-14 |
| Normal-vs-Stage2 |
4.045000E-03 |
| Normal-vs-Stage3 |
2.80609979697033E-11 |
| Normal-vs-Stage4 |
2.37010411296978E-12 |
| Stage1-vs-Stage2 |
3.093400E-01 |
| Stage1-vs-Stage3 |
4.575600E-01 |
| Stage1-vs-Stage4 |
9.536200E-01 |
| Stage2-vs-Stage3 |
2.003400E-01 |
| Stage2-vs-Stage4 |
3.171400E-01 |
| Stage3-vs-Stage4 |
5.372200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85196302737722E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.782100E-02 |
| Caucasian-vs-AfricanAmerican |
1.164010E-04 |
| Caucasian-vs-Asian |
6.739600E-01 |
| AfricanAmerican-vs-Asian |
1.533980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.85882428840978E-13 |
| Normal-vs-Female |
1.64046554118613E-12 |
| Male-vs-Female |
5.795000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.03149727542973E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(61-80Yrs) |
2.17303952609882E-12 |
| Normal-vs-Age(81-100Yrs) |
3.504600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.081800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.584750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.084200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.921000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.973400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.528600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.62481139653892E-12 |
| Normal-vs-Grade 2 |
4.25599555597955E-11 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.64002145197628E-12 |
| Grade 1-vs-Grade 2 |
3.384200E-03 |
| Grade 1-vs-Grade 3 |
1.642210E-02 |
| Grade 1-vs-Grade 4 |
1.557810E-01 |
| Grade 2-vs-Grade 3 |
2.845800E-01 |
| Grade 2-vs-Grade 4 |
1.433430E-01 |
| Grade 3-vs-Grade 4 |
5.390800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.626032641866E-12 |
| Normal-vs-ccB subtype |
4.53949999812409E-09 |
| ccA subtype-vs-ccB subtype |
6.244100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53352894219461E-12 |
| Normal-vs-N1 |
2.14909999999291E-05 |
| N0-vs-N1 |
8.248400E-01 |
|
|
